Highlights from the canadian bladder cancer network.
作者信息
Siemens D Robert
出版信息
Can Urol Assoc J. 2011 Apr;5(2):77. doi: 10.5489/cuaj.11040.
Abstract
摘要
相似文献
1
Highlights from the canadian bladder cancer network.加拿大膀胱癌网络亮点。
Can Urol Assoc J. 2011 Apr;5(2):77. doi: 10.5489/cuaj.11040.
2
Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience.根治性膀胱切除术治疗T1期膀胱癌：加拿大膀胱癌网络的经验。
Can Urol Assoc J. 2011 Apr;5(2):83-7. doi: 10.5489/cuaj.10040.
3
Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.基于膀胱癌根治性膀胱切除术后复发模式的监测指南：加拿大膀胱癌网络的经验
BJU Int. 2012 Nov;110(9):1324. doi: 10.1111/j.1464-410X.2012.11158.x. Epub 2012 Apr 13.
4
Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.加拿大膀胱癌护理持续优化：第三届加拿大膀胱癌-加拿大泌尿外科学会-加拿大泌尿肿瘤学组（BCC-CUA-CUOG）膀胱癌护理质量共识会议总结
Can Urol Assoc J. 2020 Mar;14(3):E115-E125. doi: 10.5489/cuaj.6378. Epub 2020 Feb 3.
6
Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.基于膀胱癌根治性膀胱切除术后复发模式的监测指南：加拿大膀胱癌网络的经验。
BJU Int. 2012 Nov;110(9):1317-23. doi: 10.1111/j.1464-410X.2012.11133.x. Epub 2012 Apr 13.
7
Silica and asbestos exposure at work and the risk of bladder cancer in Canadian men: a population-based case-control study.工作场所中二氧化硅和石棉暴露与加拿大男性膀胱癌风险的关系：一项基于人群的病例对照研究。
BMC Cancer. 2020 Mar 3;20(1):171. doi: 10.1186/s12885-020-6644-7.
8
Building a Canadian Translational Bladder Cancer Research Network.建立一个加拿大膀胱癌转化研究网络。
Can Urol Assoc J. 2020 Oct;14(10):E475-E481. doi: 10.5489/cuaj.6887.
9
The Canadian Bladder Cancer Network: efforts to improve patient care.加拿大膀胱癌网络：改善患者护理的努力。
Can Urol Assoc J. 2011 Apr;5(2):88. doi: 10.5489/cuaj.11050.
10
Building the Canadian Bladder Cancer Research Network (CBCRN): Progress during a pandemic.构建加拿大膀胱癌研究网络（CBCRN）：疫情期间的进展
Can Urol Assoc J. 2022 Jun;16(6):E307-E314. doi: 10.5489/cuaj.7810.
本文引用的文献
1
Emerging novel therapies in the treatment of castrate-resistant prostate cancer.去势抵抗性前列腺癌治疗中的新兴新型疗法。
Can Urol Assoc J. 2011 Apr;5(2):120-33. doi: 10.5489/cuaj.10160.
2
Multivariate analysis of the factors involved in loss of renal differential function after laparoscopic partial nephrectomy: a role for warm ischemia time.腹腔镜肾部分切除术后肾差异功能丧失相关因素的多变量分析：热缺血时间的作用
Can Urol Assoc J. 2011 Apr;5(2):89-95. doi: 10.5489/cuaj.10044.
3
Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience.根治性膀胱切除术治疗T1期膀胱癌：加拿大膀胱癌网络的经验。
Can Urol Assoc J. 2011 Apr;5(2):83-7. doi: 10.5489/cuaj.10040.
4
Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.加拿大非肌肉浸润性膀胱癌治疗指南：聚焦膀胱内治疗
Can Urol Assoc J. 2010 Jun;4(3):168-73. doi: 10.5489/cuaj.10051.
5
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.接受根治性膀胱切除术治疗的临床 T1 级 3 级尿路上皮癌患者的特征和结局：来自国际队列的结果。
Eur Urol. 2010 Feb;57(2):300-9. doi: 10.1016/j.eururo.2009.09.024. Epub 2009 Sep 12.
6
An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.对新诊断的高级别 T1（以前为 T1G3）膀胱癌的治疗策略进行的最新批判性分析。
Eur Urol. 2010 Jan;57(1):60-70. doi: 10.1016/j.eururo.2009.08.024. Epub 2009 Sep 1.
7
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.欧洲泌尿外科学会膀胱非肌层浸润性尿路上皮癌指南
Eur Urol. 2008 Aug;54(2):303-14. doi: 10.1016/j.eururo.2008.04.051. Epub 2008 Apr 30.
Zotero 插件